Dr. Oh on the Hormone-Sensitive Setting in Prostate Cancer

William K. Oh, MD
Published: Friday, Jan 05, 2018



William K. Oh, MD, chief, Division of Hematology and Medical Oncology, professor of medicine and urology, Mount Sinai Hospital, discusses the hormone-sensitive setting of prostate cancer.

The hormone-sensitive setting is a good area to test new regimens since things happen quickly, according to Oh. Since patients present with metastatic disease, their overall outcomes may be limited, but drugs will continue to be developed in this space.
 


William K. Oh, MD, chief, Division of Hematology and Medical Oncology, professor of medicine and urology, Mount Sinai Hospital, discusses the hormone-sensitive setting of prostate cancer.

The hormone-sensitive setting is a good area to test new regimens since things happen quickly, according to Oh. Since patients present with metastatic disease, their overall outcomes may be limited, but drugs will continue to be developed in this space.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 1st Annual International Congress of Oncology Pathology™: Towards Harmonization of Pathology and Oncology StandardsAug 30, 20182.0
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Publication Bottom Border
Border Publication
x